Ranbaxy Laboratories shines on launching hybrid business in Brazil with Daiichi Sankyo

18 Apr 2013 Evaluate

Ranbaxy Laboratories is currently trading at Rs. 451.40, up by 6.10 points or 1.37% from its previous closing of Rs. 445.30 on the BSE.

The scrip opened at Rs. 447.95 and has touched a high and low of Rs. 453.45 and Rs. 447.60 respectively. So far 16,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 578.30 on 04-Sep-2012 and a 52 week low of Rs. 370.50 on 01-Mar-2013.

Last one week high and low of the scrip stood at Rs. 453.70 and Rs. 435.40 respectively. The current market cap of the company is Rs. 19,094 crore.

The promoters holding in the company stood at 63.52% while Institutions and Non-Institutions held 20.58% and 13.80% respectively.

Ranbaxy Laboratories and Daiichi Sankyo Company collaborated in Brazil to expand the business of both companies in the country. As part of this synergy, Ranbaxy will support Daiichi Sankyo's Brazilian subsidiary, Daiichi Sankyo Brasil Farmaceutica, to enter the branded generics market, in addition to its established business of providing innovative products. Ranbaxy's Brazilian subsidiary, Ranbaxy Farmaceutica would continue to independently promote Ranbaxy's generic products and also enter into branded generics in Brazil.

The pharmaceutical market in Brazil is the biggest in Latin America, and it is expected to become the fourth biggest in the world in 2016. In Brazil, Daiichi Sankyo has built up its market presence with innovative pharmaceuticals through Daiichi Sankyo Brazil. On the other hand, Ranbaxy markets its generic products in Brazil through its subsidiary, Ranbaxy Farmaceutica.

Ranbaxy Laboratories is India's largest pharmaceutical company. The company has global presence in 49 countries and is ranked amongst top ten global generics companies. Ranbaxy has world-class manufacturing facilities in 11 countries namely Brazil, China, Ireland, India, Japan, Malaysia, Nigeria, Romania, South Africa, USA and Vietnam.

Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×